NCT07372820 METABolic Deterioration in HTX Determines Outcomes
| NCT ID | NCT07372820 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Heinrich-Heine University, Duesseldorf |
| Condition | Heart Transplantation |
| Study Type | OBSERVATIONAL |
| Enrollment | 270 participants |
| Start Date | 2025-07-24 |
| Primary Completion | 2030-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 270 participants in total. It began in 2025-07-24 with a primary completion date of 2030-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Eligibility Criteria
Inclusion Criteria: * Age: ≥ 18 years * Planned or already conducted heart transplantation * Informed consent Exclusion Criteria: * Absence of informed consent
Contact & Investigator
Malte Kelm, Prof.
STUDY CHAIR
Clinic of Cardiology, Pneumology and Vascular Medicine at University Hospital Düsseldorf
Frequently Asked Questions
Who can join the NCT07372820 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07372820 currently recruiting?
Yes, NCT07372820 is actively recruiting participants. Contact the research team at amin.polzin@med.uni-duesseldorf.de for enrollment information.
Where is the NCT07372820 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT07372820 clinical trial?
NCT07372820 is sponsored by Heinrich-Heine University, Duesseldorf. The principal investigator is Malte Kelm, Prof. at Clinic of Cardiology, Pneumology and Vascular Medicine at University Hospital Düsseldorf. The trial plans to enroll 270 participants.